LEUCOVORIN

This brand name is authorized in Australia, Estonia, Hong Kong SAR China, Israel, Japan, New Zealand, Turkey.

Active ingredients

The drug LEUCOVORIN contains one active pharmaceutical ingredient (API):

1	Calcium folinate UNII 935E97BOY8 - FOLIC ACID
	Calcium folinate is an active metabolite of folinic acid and essential coenzyme for nucleic acid synthesis in cytotoxic therapy. Calcium folinate is frequently used to diminish the toxicity and counteract the action of folate antagonists, such as methotrexate.
	Read more about Calcium folinate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AF03	Calcium folinate	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1610R, 1704Q, 1899Y, 1904F, 2308L, 5904R
EE	Ravimiamet	1612202, 1780107
HK	Department of Health Drug Office	35172
IL	מִשְׂרַד הַבְּרִיאוּת	1387, 8845, 8856
JP	医薬品医療機器総合機構	3929004F2030
NZ	Medicines and Medical Devices Safety Authority	3632, 3633, 3634, 8641
TR	İlaç ve Tıbbi Cihaz Kurumu	8699638770250, 8699638770267, 8699638770274, 8699638770281